• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancer.

作者信息

Thiery-Vuillemin A, Curtit E, Maurina T, Montange D, Succi C, NGuyen T, Kim S, Montcuquet P, Pivot X, Royer B

机构信息

INSERM, UMR1098, Besançon; UMR1098, SFR IBCT, University of Franche-Comté, Besançon, France; Medical Oncology Unit, CHU Minjoz, Besançon.

Medical Oncology Unit, CHU Minjoz, Besançon.

出版信息

Ann Oncol. 2012 Nov;23(11):2992-2993. doi: 10.1093/annonc/mds477. Epub 2012 Oct 15.

DOI:10.1093/annonc/mds477
PMID:23071263
Abstract
摘要

相似文献

1
Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancer.
Ann Oncol. 2012 Nov;23(11):2992-2993. doi: 10.1093/annonc/mds477. Epub 2012 Oct 15.
2
Prolonged survival in renal transplant recipient with advanced renal cell carcinoma by everolimus and sorafenib.依维莫司和索拉非尼使晚期肾细胞癌肾移植受者长期存活。
Nephrology (Carlton). 2011 Jan;16(1):118-9. doi: 10.1111/j.1440-1797.2010.01346.x.
3
A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma.一项在晚期肾细胞癌患者中使用瓦他拉尼和依维莫司联合抑制VEGFR和mTOR的Ib期研究。
Clin Genitourin Cancer. 2014 Aug;12(4):241-50. doi: 10.1016/j.clgc.2013.11.020. Epub 2013 Nov 14.
4
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer.AZD2014 与依维莫司治疗血管内皮生长因子受体(VEGF-R)耐药转移性肾透明细胞癌的随机 2 期研究。
Eur Urol. 2016 Mar;69(3):450-6. doi: 10.1016/j.eururo.2015.08.035. Epub 2015 Sep 11.
5
Everolimus for the treatment of advanced renal cell carcinoma.依维莫司治疗晚期肾细胞癌。
Expert Opin Pharmacother. 2011 May;12(7):1143-55. doi: 10.1517/14656566.2011.571382. Epub 2011 Apr 7.
6
Efficacy of everolimus in patients with advanced renal cell carcinoma refractory or intolerant to VEGFR-TKIs and safety compared with prior VEGFR-TKI treatment.依维莫司治疗晚期肾细胞癌患者的疗效：在对 VEGFR-TKIs 耐药或不耐受的患者中的应用及与既往 VEGFR-TKI 治疗相比的安全性。
Jpn J Clin Oncol. 2014 May;44(5):479-85. doi: 10.1093/jjco/hyu018. Epub 2014 Mar 30.
7
Outcomes of patients with metastatic renal cell carcinoma and end-stage renal disease receiving dialysis and targeted therapies: a single institution experience.接受透析和靶向治疗的转移性肾细胞癌及终末期肾病患者的治疗结果：单机构经验
Clin Genitourin Cancer. 2014 Oct;12(5):348-53. doi: 10.1016/j.clgc.2014.01.004. Epub 2014 Jan 18.
8
Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies.采用 VEGF 靶向治疗药物治疗依维莫司耐药转移性肾细胞癌。
Br J Cancer. 2011 Nov 22;105(11):1635-9. doi: 10.1038/bjc.2011.389. Epub 2011 Oct 27.
9
Phase III trial of everolimus in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from RECORD-1.RECORD-1 研究中转移性肾细胞癌患者的依维莫司 III 期临床试验：日本患者亚组分析
Jpn J Clin Oncol. 2011 Jan;41(1):17-24. doi: 10.1093/jjco/hyq166. Epub 2010 Oct 21.
10
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.卡博替尼与依维莫司治疗晚期肾细胞癌的疗效对比
N Engl J Med. 2015 Nov 5;373(19):1814-23. doi: 10.1056/NEJMoa1510016. Epub 2015 Sep 25.

引用本文的文献

1
Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function.针对肾功能正常和受损患者的肾癌的靶向治疗的肾毒性。
Cancer Chemother Pharmacol. 2021 Jun;87(6):723-742. doi: 10.1007/s00280-021-04260-y. Epub 2021 Mar 25.
2
Renal angiomyolipomatosis and bleeding aneurysms in a tuberous sclerosis context: selective artery embolization in a girl with end-stage renal failure.结节性硬化症背景下的肾血管平滑肌脂肪瘤和出血性动脉瘤：一名终末期肾衰竭女孩的选择性动脉栓塞治疗
Pediatr Rep. 2020 Aug 6;12(2):8352. doi: 10.4081/pr.2020.8352.
3
Metastatic epithelioid angiomyolipoma treated with everolimus in a patient receiving hemodialysis: A case report.
IJU Case Rep. 2019 Jul 9;2(5):279-282. doi: 10.1002/iju5.12103. eCollection 2019 Sep.
4
Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: case report and literature review.依维莫司治疗血液透析伴转移非典型性支气管类癌患者的疗效和安全性：病例报告及文献复习。
BMC Cancer. 2018 Mar 20;18(1):311. doi: 10.1186/s12885-018-4205-0.
5
Pharmacokinetics of gefitinib in a patient with non-small cell lung cancer undergoing continuous ambulatory peritoneal dialysis.吉非替尼在一名接受持续非卧床腹膜透析的非小细胞肺癌患者中的药代动力学。
Case Rep Oncol. 2015 Feb 11;8(1):78-82. doi: 10.1159/000375485. eCollection 2015 Jan-Apr.
6
Renal effects of targeted anticancer therapies.靶向抗癌疗法的肾脏效应。
Nat Rev Nephrol. 2015 Jun;11(6):354-70. doi: 10.1038/nrneph.2015.15. Epub 2015 Mar 3.
7
Treatment of patients with metastatic renal cell carcinoma undergoing hemodialysis: case report of two patients and short literature review.接受血液透析的转移性肾细胞癌患者的治疗：两例病例报告及文献综述
BMC Nephrol. 2013 Apr 12;14:84. doi: 10.1186/1471-2369-14-84.